Kimura Akihiro, Naka Tetsuji, Kishimoto Tadamitsu
Laboratory of Immune Regulation, Osaka University Graduate School of Frontier Biosciences, 1-3, Yamada-oka, Suita, Osaka, 565-0871, Japan.
Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12099-104. doi: 10.1073/pnas.0705268104. Epub 2007 Jul 10.
CD4(+) T cells producing IL-17 [T helper (Th)17], as distinct from Th1 or Th2 cells, have recently been shown to be associated with autoimmunity, but it is not entirely clear how Th17 cells are generated from naïve T cells. We demonstrate here that IL-6, but not TNF-alpha or IL-1beta, can, in combination with TGF-beta, induce Th17 cell generation from naïve T cells and inhibit TGF-beta-induced Foxp3 expression. Moreover, conditioned medium from lipopolysaccharide-stimulated bone marrow-derived dendritic cells (DCCM) can induce IL-17 production in naïve T cells. Interestingly, IL-17 was produced by DCCM even with the addition of anti-gp130 antibody or DCCM from IL-6 KO mice. The combination of IL-6 and TGF-beta could maintain activation of signal transducer and activator of transcription (Stat)3, but not of Stat1. IL-27 or IFN-gamma suppressed the induction of Th17 cells by TGF-beta plus IL-6 and maintained Stat1 activation under these conditions. In contrast, both Stat1 and Stat3 remained to be activated in naïve T cells cultured with DCCM. These findings represent a different basis for Th17 differentiation from naïve T cells.
与Th1或Th2细胞不同,产生白细胞介素17(IL-17)的CD4(+) T细胞[辅助性T细胞(Th)17]最近已被证明与自身免疫有关,但尚不完全清楚初始T细胞如何分化为Th17细胞。我们在此证明,IL-6与转化生长因子-β(TGF-β)联合使用时可诱导初始T细胞生成Th17细胞,而肿瘤坏死因子-α(TNF-α)或白细胞介素1β(IL-1β)则不能,并且IL-6还可抑制TGF-β诱导的叉头框蛋白3(Foxp3)表达。此外,脂多糖刺激的骨髓来源树突状细胞的条件培养基(DCCM)可诱导初始T细胞产生IL-17。有趣的是,即使添加抗gp130抗体或使用来自IL-6基因敲除小鼠的DCCM,DCCM仍可产生IL-17。IL-6和TGF-β的组合可维持信号转导和转录激活因子(Stat)3的激活,但不能维持Stat1的激活。在这些条件下,IL-27或干扰素-γ(IFN-γ)可抑制TGF-β加IL-6诱导的Th17细胞生成,并维持Stat1的激活。相反,在用DCCM培养的初始T细胞中,Stat1和Stat3均保持激活状态。这些发现代表了初始T细胞向Th17细胞分化的不同机制。